Niklas Axén
Corporate Officer/Principal at LIDDS AB
Network origin in Niklas Axén first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
28
| Public Company | Pharmaceuticals: Major | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Niklas Axén via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PROBI AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer | |
| VITROLIFE AB | Medical Specialties | Public Communications Contact | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Concordia University | College/University | Masters Business Admin | |
| Chalmers University of Technology | College/University | Undergraduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Lund | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
| University of Gothenburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Chairman | |
| Handelshögskolan i Göteborg | College/University | Graduate Degree | |
SP Sveriges Tekniska Forskningsinstitut AB
 SP Sveriges Tekniska Forskningsinstitut AB Miscellaneous Commercial ServicesCommercial Services SP Sveriges Tekniska Forskningsinstitut AB operates as a international research institute. Its business areas include energy, information and communications technology, life science, risk, safety and security, the built environment and transportation. The company was founded in 1920 and is headquartered in Borås, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ellet Assets AB
 Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
DuoCort Pharma AB
 DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| MENDUS AB | Biotechnology | Chairman | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Mabtech AB
 Mabtech AB Miscellaneous Commercial ServicesCommercial Services Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
| Glactone Pharma Development AB | Chairman | ||
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Diaprost AB
 Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
| CYXONE AB | Pharmaceuticals: Major | Chairman | |
| Innoex AB | Chief Executive Officer | ||
| Stayble AB | Director/Board Member | ||
Truly Labs AB
 Truly Labs AB Medical/Nursing ServicesHealth Services Truly Labs AB is a Contract Research Organization that provides customized in vitro and in vivo services to its customers. The Swedish company offers a wide range of in vitro services, including cell-based assays such as mode-of-action and efficacy assays, and biomarker analysis. The private company specializes in inhalation, which is relevant for all therapeutic indications where systemic exposure is desired. The company also has a podcast called "Lung in the Lunch and Learn," where the CEO, Karin von Wachenfeldt, and Lars Asking from MVIC AB discuss inhalation. | Medical/Nursing Services | Director/Board Member | |
| BICO GROUP AB | Biotechnology | Chief Executive Officer | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| SCANDINAVIAN CHEMOTECH AB | Medical Specialties | Chairman | |
| DICOT PHARMA AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| BIOME AUSTRALIA LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Northern Lights Southern Cross AB | Chief Executive Officer | ||
Nöbbe Gård Projekt AB
 Nöbbe Gård Projekt AB Advertising/Marketing ServicesCommercial Services Nöbbe Gård Projekt AB is a private company based in Malmö, Sweden. The Swedish company operates as a platform for condominium associations and residents in condominiums. | Advertising/Marketing Services | Director/Board Member | |
| Lu Bioscience AB | Director/Board Member | ||
Innoext AB
 Innoext AB Miscellaneous Commercial ServicesCommercial Services Innoext AB provides management consulting services. The private company is based in Västra Frölunda, Sweden. Jan Birger Fredrik Toernell has been the CEO of the Swedish company since 2011. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Bico International AB | Chairman | ||
| Fastighets AB Olshög | Chief Executive Officer |
Statistics
International
| Sweden | 43 |
| Denmark | 4 |
| Australia | 3 |
| United Kingdom | 2 |
| Norway | 2 |
Sectoral
| Health Technology | 23 |
| Commercial Services | 11 |
| Consumer Services | 9 |
| Process Industries | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 83 |
| Corporate Officer/Principal | 52 |
| Chief Executive Officer | 43 |
| Chairman | 42 |
| Independent Dir/Board Member | 21 |
Most connected contacts
- Stock Market
- Insiders
- Niklas Axén
- Company connections
